In liver and colon cancers, elevated expression of ICAM-1, VCAM-1, and MAdCAM-1, ligands to leukocyte-specific integrins, have shown improved T-cells penetration of the tumor and prognosis on patients’ survival [152,153]. Here, VCAM1 is linked to neoplasm.